Brochure: XD® Technology: Improve Biopharmaceutical Production

DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals. XD® is able to push the cell density within the bioreactor to the max and thereby achieve maximum productivity.

Keep the environment of your manufacturing cells constant and increase the cell density by consistent nutrient supply. At the end of the cultivation (14 days) the complete harvest will be processed as in any other fed-batch process. During cultivation the medium will be replenished based on the needs of the cells, while the cells and the product are retained in the reactor with a retention device.